Embolic protection devices are designed to capture and remove debris during cardiac procedures. Embolic protection devices are mainly used for applications in which veins are 2.5 – 5.5mm in diameter.
Major factor driving growth of the global embolic protection devices market is increasing geriatric population across the globe, which is more susceptible to cardiovascular diseases (CVD). Additionally, increasing investments in research & development and embolic protection devices minimize trauma and also reduce the risks of blood vessels infection which are other factors expected to propel growth of the global market over the forecast period. But, presence of alternative treatment methods such as endarterectomy and stringent government regulations on product approvals are major factors expected to hamper growth of the target market over the forecast period.
The global embolic protection devices market is segmented into type, material, application, end user, and region. On the basis of type, the target market is segmented into distal filter devices, distal occlusion devices, and proximal occlusion devices. Among the type segments, the distal occlusion devices segment is expected to witness considerable growth and is projected to register highest CAGR in the target market over the forecast period.
On the basis of material, the target market is segmented into nitinol and polyurethane. On the basis of application, the target market is segmented into cardiovascular diseases, neurovascular diseases, and peripheral vascular diseases. On the basis of end user, the target market is segmented into hospitals and ambulatory surgical centers. On the basis of region, the target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Do Inquiry of the Report Here: https://marketresearch.biz/report/embolic-protection-devices-market/#inquiry
North America market accounted for highest share in terms of revenue in the global market, as compared to that of markets in other regions. This can be attributed to presence of prominent venders in countries in the region. The market in Asia Pacific is expected to witness considerable growth and is projected to register highest CAGR of X.X% over the forecast period, owing to increasing investments into development of proper healthcare infrastructure in emerging economies such as China, India, etc.
Key players in the global embolic protection devices market include Medtronic, Inc., Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Inc., Contego Medical, LLC, W. L. Gore & Associates, Inc., Silk Road Medical, Inc., Claret Medical, Inc., Allium Medical Solutions Ltd., and AngioSlide, Ltd.